Emily Luisa Hill, CFO of Replimune Group REPL, has filed 0 purchases and 10 sales on the open market. Over the past 12 months that comes to a net sale of $39.7K. The latest trade was on 05/18.

EH

EH

Emily Luisa Hill

CFO

Company

Replimune Group REPL

First filing

23/01/09

Trades

21 trades

Buys / sales

0 / 10

12-month net buying

−$39.7K

Last trade

05/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Replimune GroupREPL	Open-market sale	05/18	05/20	7,812 sh	$5.08	$39,684.96	−3.2%
Replimune GroupREPL	Open-market sale	25/08/15	25/08/19	9,154 sh	$5.37	$49,156.98	−6.4%
Replimune GroupREPL	Open-market sale	25/05/20	25/05/22	2,535 sh	$8.05	$20,406.75	−1.7%
Replimune GroupREPL	Open-market sale	24/08/16	24/08/19	8,938 sh	$10.18	$90,988.84	−8.1%
PTC TherapeuticsPTCT	Open-market sale10b5-1 plan	23/03/27	23/03/29	7,363 sh	$45.00	$331,335	−15.9%
PTC TherapeuticsPTCT	Open-market sale	23/01/31	23/02/02	575 sh	$45.63	$26,237.25	−1.2%
PTC TherapeuticsPTCT	Open-market sale	23/01/24	23/01/26	223 sh	$47.45	$10,581.35	−0.5%
PTC TherapeuticsPTCT	Open-market sale	23/01/10–23/01/11	23/01/12	915 sh2 trades	$43.58avg.	$39,878.69	−1.9%
PTC TherapeuticsPTCT	Open-market sale	23/01/09	23/01/11	758 sh	$41.66	$31,578.28	−1.6%